View details of this raise on Seedstage

Bedford, MA

Developing a space-validated blood diagnostics platform for consumer and point-of-care use.

• Portable Diagnostic Platform: rHEALTH is creating a handheld device for rapid, lab-quality blood diagnostics using a single drop of blood.
• Space-Validated Technology: The platform has been tested on the International Space Station, ensuring its reliability in extreme conditions.
• Expert-Led Team: The team includes Harvard and MIT-trained professionals with collaborations with NASA and NIH.
• Extensive Patent Portfolio: rHEALTH holds 17 issued patents, supporting its innovative approach to diagnostics.
• AI-Driven Software: The platform uses AI for interpreting diagnostic results, enhancing accuracy and efficiency.

rHEALTH is developing a portable diagnostic platform initially designed for space applications, now being adapted for everyday healthcare use. The platform aims to provide rapid, lab-quality blood diagnostics from a single drop, utilizing nanoscale test strips, hardware, consumables, and AI-driven software interpretation. This technology allows tests traditionally performed in central labs to be conducted at the point-of-care, including blood counts, biomarkers, chemistry, coagulation, and nucleic acid tests. The company’s goal is to decentralize and improve access to health information without the need for hospitals.

Led by a team with expertise from Harvard, MIT, and collaborations with NASA and NIH, rHEALTH has developed technologies validated on the International Space Station. With 17 issued patents and $23M in funding, the platform is positioned to enhance healthcare diagnostics both in space and on Earth. The company is working towards FDA approval to bring this technology to pharmacies, urgent care centers, and homes, aiming to make advanced diagnostics accessible in various settings.

Company Info

rHEALTH develops a portable, space-validated blood diagnostics platform for consumer and point-of-care use.

rHEALTH is a med-tech company focused on developing a portable blood diagnostics platform that was originally designed for space applications. The platform is capable of performing lab-quality diagnostics from a single drop of blood, utilizing nanoscale test strips, hardware, consumables, and AI-driven software for interpretation. This technology aims to decentralize healthcare diagnostics, making it accessible outside traditional hospital settings, including homes and point-of-care locations.

The company collaborates with NASA and other major institutions, leveraging its space-validated technology to provide rapid and reliable diagnostic results. With a team led by Harvard/MIT-trained MD Eugene Chan, rHEALTH has developed a system that integrates miniaturized flow cytometry and multiplexed assay technology. The platform has been tested on the International Space Station and holds 17 issued patents, positioning it to potentially transform the way diagnostics are conducted both in space and on Earth.